The mission of the Clinical Trials Office (CTO) Shared Resource is to provide a supportive environment for the successful conduct of clinical trials in order to facilitate and promote clinical research within the UCSD Cancer Center. One of the fundamental activities of a cancer center is the translation of novel scientific information into new treatments for patients with cancer. This cannot be accomplished without an efficiently functioning infrastructure to support the clinical investigator in this endeavor. CTO services are provided to all principal investigators within the Cancer Center as evidence of value added for membership. It provides centralized administrative and management support for all clinical trials at every stage of development from inception to completion. Services include: (1) Assistance with protocol preparation. We have developed a CTO Handbook that provides specific instructions for protocol preparation and which is also a complete guide to protocol management; (2) Assistance in protocol preparation for submission to the UCSD Protocol Review Monitoring Committee as well as the Institutional Review Board. We assist in the preparation of the IRB application and protocol consent form; (3) Assistance in the preparation of the protocol for submission to outside regulatory bodies (e.g. FDA) and/or pharmaceutical companies; (4) Assistance in budget preparation for submission to extramural funding entities; (5) Following activation of a protocol, we provide complete CRA and data management support; (6) Assist in the identification of potential patients of all protocols that we manage; (7) Wide dissemination of information of information regarding active protocols to internal and other physicians through the use of printed and electronic media. We have developed and published a """"""""Protocol Handbook) that is provided to all investigators. Additionally, we participate in the maintenance of the UCSD Cancer Center Web Site wherein information on all protocols is provided. As evidence of the importance of this infrastructure, much of it implemented since 1998, we have increased the number of UCSD sponsored clinical trials by 30%, and have increased our accrual to clinical trials to 230% of the previous levels. Continued efforts are underway to further increase both the number of active trials and accrual through recruitment of faculty with established track records in clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA023100-18S1
Application #
6501410
Study Section
Project Start
2001-06-21
Project End
2002-04-30
Budget Start
Budget End
Support Year
18
Fiscal Year
2001
Total Cost
$183,723
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Norton, Jeffrey A; Kim, Teresa; Kim, Joseph et al. (2018) SSAT State-of-the-Art Conference: Current Surgical Management of Gastric Tumors. J Gastrointest Surg 22:32-42
Ikeda, Sadakatsu; Tsigelny, Igor F; Skjevik, Åge A et al. (2018) Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma. Oncologist 23:586-593
Buckley, Alexandra R; Ideker, Trey; Carter, Hannah et al. (2018) Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas. Genome Med 10:69
Parish, Austin J; Nguyen, Vi; Goodman, Aaron M et al. (2018) GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. Cancer 124:4080-4089
Xu, Selene; Thompson, Wesley; Ancoli-Israel, Sonia et al. (2018) Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships. Psychooncology 27:802-809
Tao, Li; Schwab, Richard B; San Miguel, Yazmin et al. (2018) Breast Cancer Mortality in Older and Younger Breast Cancer Patients in California. Cancer Epidemiol Biomarkers Prev :
Sagredo, Eduardo A; Blanco, Alejandro; Sagredo, Alfredo I et al. (2018) ADAR1-mediated RNA-editing of 3'UTRs in breast cancer. Biol Res 51:36
Ramdani, Ghania; Schall, Nadine; Kalyanaraman, Hema et al. (2018) cGMP-dependent protein kinase-2 regulates bone mass and prevents diabetic bone loss. J Endocrinol 238:203-219
Nguyen, Vi; Marmor, Rebecca A; Ramamoorthy, Sonia L et al. (2018) The Use of Solicited Publishing by Academic Surgeons. Surgery 164:212-218
Yan, Wei; Wu, Xiwei; Zhou, Weiying et al. (2018) Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 20:597-609

Showing the most recent 10 out of 862 publications